60 related articles for article (PubMed ID: 11809726)
1. Rescue of polyglutamine-mediated cytotoxicity by double-stranded RNA-mediated RNA interference.
Caplen NJ; Taylor JP; Statham VS; Tanaka F; Fire A; Morgan RA
Hum Mol Genet; 2002 Jan; 11(2):175-84. PubMed ID: 11809726
[TBL] [Abstract][Full Text] [Related]
2. Inducing RNAi in Drosophila cells by soaking with dsRNA.
Zhou R; Mohr S; Hannon GJ; Perrimon N
Cold Spring Harb Protoc; 2014 May; 2014(5):. PubMed ID: 24786505
[TBL] [Abstract][Full Text] [Related]
3. Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice.
Rodriguez-Lebron E; Denovan-Wright EM; Nash K; Lewin AS; Mandel RJ
Mol Ther; 2005 Oct; 12(4):618-33. PubMed ID: 16019264
[TBL] [Abstract][Full Text] [Related]
4. Plasmids Expressing shRNAs Specific to the Nucleocapsid Gene Inhibit the Replication of Porcine Deltacoronavirus In Vivo.
Gu J; Li H; Bi Z; Li K; Li Z; Song D; Ding Z; He H; Wu Q; Huang D; Gan P; Ye Y; Tang Y
Animals (Basel); 2021 Apr; 11(5):. PubMed ID: 33922444
[TBL] [Abstract][Full Text] [Related]
5. Cancer biology functional genomics: From small RNAs to big dreams.
Sundara Rajan S; Ludwig KR; Hall KL; Jones TL; Caplen NJ
Mol Carcinog; 2020 Dec; 59(12):1343-1361. PubMed ID: 33043516
[TBL] [Abstract][Full Text] [Related]
6. Suppression of Mutant Protein Expression in SCA3 and SCA1 Mice Using a CAG Repeat-Targeting Antisense Oligonucleotide.
Kourkouta E; Weij R; González-Barriga A; Mulder M; Verheul R; Bosgra S; Groenendaal B; Puoliväli J; Toivanen J; van Deutekom JCT; Datson NA
Mol Ther Nucleic Acids; 2019 Sep; 17():601-614. PubMed ID: 31394429
[TBL] [Abstract][Full Text] [Related]
7. ASPsiRNA: A Resource of ASP-siRNAs Having Therapeutic Potential for Human Genetic Disorders and Algorithm for Prediction of Their Inhibitory Efficacy.
Monga I; Qureshi A; Thakur N; Gupta AK; Kumar M
G3 (Bethesda); 2017 Sep; 7(9):2931-2943. PubMed ID: 28696921
[TBL] [Abstract][Full Text] [Related]
8. Childhood-onset (Juvenile) Huntington's disease: A rare case report.
Patra KC; Shirolkar MS
J Pediatr Neurosci; 2015; 10(3):276-9. PubMed ID: 26557176
[TBL] [Abstract][Full Text] [Related]
9. Oligonucleotide-based strategies to combat polyglutamine diseases.
Fiszer A; Krzyzosiak WJ
Nucleic Acids Res; 2014 Jun; 42(11):6787-810. PubMed ID: 24848018
[TBL] [Abstract][Full Text] [Related]
10. Self-duplexing CUG repeats selectively inhibit mutant huntingtin expression.
Fiszer A; Olejniczak M; Galka-Marciniak P; Mykowska A; Krzyzosiak WJ
Nucleic Acids Res; 2013 Dec; 41(22):10426-37. PubMed ID: 24038471
[TBL] [Abstract][Full Text] [Related]
11. New routes to therapy for spinal and bulbar muscular atrophy.
Rocchi A; Pennuto M
J Mol Neurosci; 2013 Jul; 50(3):514-23. PubMed ID: 23420040
[TBL] [Abstract][Full Text] [Related]
12. Spinocerebellar ataxia type 2: clinical presentation, molecular mechanisms, and therapeutic perspectives.
Magaña JJ; Velázquez-Pérez L; Cisneros B
Mol Neurobiol; 2013 Feb; 47(1):90-104. PubMed ID: 22996397
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of oligonucleotide-based therapeutic strategies for polyQ diseases.
Fiszer A; Olejniczak M; Switonski PM; Wroblewska JP; Wisniewska-Kruk J; Mykowska A; Krzyzosiak WJ
BMC Mol Biol; 2012 Mar; 13():6. PubMed ID: 22397573
[TBL] [Abstract][Full Text] [Related]
14. Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target.
Krzyzosiak WJ; Sobczak K; Wojciechowska M; Fiszer A; Mykowska A; Kozlowski P
Nucleic Acids Res; 2012 Jan; 40(1):11-26. PubMed ID: 21908410
[TBL] [Abstract][Full Text] [Related]
15. Oligonucleotide therapeutic approaches for Huntington disease.
Sah DW; Aronin N
J Clin Invest; 2011 Feb; 121(2):500-7. PubMed ID: 21285523
[TBL] [Abstract][Full Text] [Related]
16. Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.
Dreyer JL
Mol Biotechnol; 2011 Feb; 47(2):169-87. PubMed ID: 20862616
[TBL] [Abstract][Full Text] [Related]
17. Design of RNAi hairpins for mutation-specific silencing of ataxin-7 and correction of a SCA7 phenotype.
Scholefield J; Greenberg LJ; Weinberg MS; Arbuthnot PB; Abdelgany A; Wood MJ
PLoS One; 2009 Sep; 4(9):e7232. PubMed ID: 19789634
[TBL] [Abstract][Full Text] [Related]
18. Huntington's disease: silencing a brutal killer.
Pfister EL; Zamore PD
Exp Neurol; 2009 Dec; 220(2):226-9. PubMed ID: 19786020
[No Abstract] [Full Text] [Related]
19. Therapeutic opportunities of small interfering RNA.
Goyal BR; Patel MM; Soni MK; Bhadada SV
Fundam Clin Pharmacol; 2009 Aug; 23(4):367-86. PubMed ID: 19709318
[TBL] [Abstract][Full Text] [Related]
20. Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients.
Pfister EL; Kennington L; Straubhaar J; Wagh S; Liu W; DiFiglia M; Landwehrmeyer B; Vonsattel JP; Zamore PD; Aronin N
Curr Biol; 2009 May; 19(9):774-8. PubMed ID: 19361997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
